Cambrex IEP is located in Wiesbaden, Germany and is a world leader in bioreduction technology.
Through efficient and environmentally friendly enzymatic syntheses, Cambrex IEP is able to supply highly pure regio-, chemo- and enantioselective intermediates and APIs for the pharmaceutical industry.
Cambrex IEP provides custom development and R&D screening, in addition to pilot to commercial scale cGMP capability for a wide range of chiral syntheses.